About This Show
ReachMD brings you the latest research, announcements, and conversations from the most important medical conferences around the world. Join us on the conference floor with keynote speakers, experts, and opinion leaders.
Most Recent Episode
Highlights from ESMO 2016: The Continued Rise of Anti-PD-1 Therapy in the Treatment of NSCLC
Oct 24 16
Host: Matt Birnholz, MD
Guest: Edward S. Kim, MD, FACP
Lung cancer is the leading cause of cancer-associated mortality, with almost 225,000 new cases and over 158,000 deaths estimated in 2016 in the United States alone. Non-small cell lung cancer (NSCLC) represents approximately 85% of those cases. Join us as Dr. Birnholz and Dr. Kim review the data presented at the 2016 annual ESMO conference and discuss the continued rise of anti-PD-1 therapy in the treatment of NSCLC.